Atrion traded at $635.68 this Friday July 1st, increasing $6.82 or 1.08 percent since the previous trading session. Looking back, over the last four weeks, Atrion gained 0.04 percent. Over the last 12 months, its price rose by 5.42 percent. Looking ahead, we forecast Atrion to be priced at 618.45 by the end of this quarter and at 569.52 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Atrion 635.68 6.82 1.08% 5.42%
Cerus 5.48 0.19 3.59% -2.32%
Cooper Companies 318.51 5.39 1.72% -21.89%
Neogen 24.30 0.21 0.87% -47.29%
OraSure Technologies 2.72 0.01 0.37% -73.36%
Rockwell Medical 1.28 -0.01 -0.78% 48.41%
Sientra 0.84 0.002 0.27% -89.47%
Surmodics 37.82 0.59 1.58% -30.38%
STAAR Surgical 72.19 1.26 1.78% -50.12%
Utah Medical Products 84.74 -1.16 -1.35% -0.67%
Meridian Bioscience 30.90 0.48 1.58% 40.77%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%

Atrion Corporation (Atrion) is engaged in developing and manufacturing products primarily for medical applications. The Company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. Its medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. Its fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses in fields, such as anesthesia and oncology. Its cardiovascular product, Myocardial Protection System (MPS3), is a technology used in the open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufacture a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.